<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <title>Email Title</title>
</head>

<body>
    <table width="100%" cellpadding="0" cellspacing="0">
        <tr>
            <td align="center">
                <table width="600" cellspacing="0" cellpadding="0" border="0">
                    <!-- header -->
                    <tr>
                        <td align="center">
                            <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;vertical-align:middle; margin-bottom: 10px;">
                                <img src="https://i1.createsend1.com/ei/d/B7/A7A/B9C/024117/csimport/prime_0.png" alt="prIME Oncology" border="0" style="vertical-align:middle; margin-right: 12px; margin-bottom:15px" />professional • independent • medical • education
                            </p>
                        </td>
                    </tr>
                    <tr>
                        <td>
                            <img src="http://www.primeoncology.org/online_education/solid_tumor/2014/~/media/Images/Activity/2014/expert%20review%20dtc/Expert%20Review_banner.ashx?w=936" alt="Expert Review in Relapsed/Refractory Differentiated Thyroid Cancer" width="600" height="94" border="0" style="display:block;" />
                        </td>
                    </tr>
                    <!-- content -->
                    <tr>
                        <td style="border-right:solid #0F509B 7px; border-left:solid #0F509B 7px;" align="center">
                            <table cellspacing="0" width="560" style="border: 20px solid #fff; table-layout: fixed;" border="0">
                                <tr>
                                    <td>
                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin:0; padding: 0;display:inline;">Expert Review in Relapsed/Refractory Differentiated Thyroid Cancer</h2>

                                        <p style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;margin-top:5px;margin-bottom:0;margin-right:0;margin-left:0;font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;">This CME-certified Expert Review features discussions on relapsed/refractory differentiated thyroid cancer (DTC).</p>
                                        <p style="font-size: 14px; font-family: arial,helvetica,sans-serif;
                 color: #4c4c4c; width: 150px;">&raquo;
                                            <a href="http://www.primeoncology.org/online_education/solid_tumor/2014/expert-review-dtc.aspx" style="text-decoration:none;" target="_blank"> <strong>View Activity</strong>
                                            </a>
                                        </p>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>

                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Activity Features</h2>

                                        <table cellspacing="0" cellpadding="0" border="0" width="100%">
                                            <tr>
                                                <td valign="top">
                                                    <table cellpadding="0" cellspacing="6" border="0">
                                                        <tr>
                                                            <td>
                                                                <img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/Discussion.png" alt="icon" width="32" height="32" border="0" />
                                                            </td>
                                                            <td>
                                                                <h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">Expert Discussion</h5>
                                                            </td>
                                                        </tr>

                                                        <tr>
                                                            <td>
                                                                <img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/Download.png" alt="icon" width="32" height="32" border="0">
                                                            </td>
                                                            <td>
                                                                <h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">Downloadable Slides</h5>
                                                            </td>
                                                        </tr>

                                                        <tr>
                                                            <td>
                                                                <img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/cme.png" alt="icon" width="32" height="32" border="0">
                                                            </td>
                                                            <td>
                                                                <h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">CME-Certified</h5>
                                                            </td>
                                                        </tr>

                                                    </table>
                                                </td>
                                                <td colspan="2" align="center">
                                                    <img src="http://www.primeoncology.org/online_education/solid_tumor/2014/~/media/Images/Activity/2014/expert%20review%20dtc/er_dtc2.ashx" alt="preview" width="300" height="209" border="0" style="border-style:none;">
                                                </td>
                                            </tr>
                                        </table>


                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>
                                                   
                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Discussion Topics</h2>

                                        <ul align="left" style="margin-top:0px !important;margin-bottom:0px !important;margin-right:10px !important;margin-left:15px !important;padding-top:0px !important;padding-bottom:0px !important;padding-right:10px !important;padding-left:15px !important;font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;">
                                            <li style="margin-top:5px;margin-bottom:0px;">Incidence, histologic classification, and prognosis for thyroid cancer</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Clinical presentation of a patient with thyroid cancer</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Prognostic factors and the methods for making the diagnosis of DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Role of molecular testing and the molecular targets known in DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Initial treatment of DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Definition, prognosis, and asymptomatic characteristics of patients with radioactive iodine refractory (RAI-R) DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Treatment of RAI-R DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Ongoing clinical trial for RAI-R DTC</li>
                                        </ul>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>


                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Faculty</h2>

                                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                                            <strong>Robert E. Coleman, MD, FRCP, FRCPE</strong>
                                            <br>Medical Director
                                            <br>prIME Oncology
                                            <br>
                                        </p>
                                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                                            <strong>Rossella Elisei, MD</strong>
                                            <br>University of Pisa
                                            <br>Pisa, Italy
                                            <br>
                                        </p>
                                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                                            <strong>Barbara Jarzab, MD, PhD</strong>
                                            <br>MSC Memorial Cancer Center
                                            <br>Gliwice, Poland
                                            <br>
                                        </p>
                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>
                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Target Audience</h2>

                                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This activity is intended to meet the needs of practicing medical oncologists and other healthcare professionals involved in the treatment of patients with DTC.</p>


                                        <p style="font-size: 14px; font-family: arial,helvetica,sans-serif;
                 color: #4c4c4c; width: 150px;">&raquo;
                                            <a href="http://www.primeoncology.org/online_education/solid_tumor/2014/expert-review-dtc.aspx" style="text-decoration:none;" target="_blank"> <strong>View Activity</strong>
                                            </a>
                                        </p>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>


                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Learning Objectives</h2>

                                        <p align="left" style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;margin-top:5px;margin-bottom:0;margin-right:0;margin-left:0;font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;">After successful completion of this educational activity, participants should be able to:
                                        </p>
                                        <ul align="left" style="margin-top:0px !important;margin-bottom:0px !important;margin-right:10px !important;margin-left:15px !important;padding-top:0px !important;padding-bottom:0px !important;padding-right:10px !important;padding-left:15px !important;font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;">
                                            <li style="margin-top:5px;margin-bottom:0px;">Describe the patients’ clinical presentation, key prognostic factors, and methods for making the diagnosis of DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Apply recent advances to the treatment of patients with RAI-R DTC, including integration of tyrosine kinase inhibitors</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Describe the role of molecular testing and the molecular targets known in DTC</li>
                                            <li style="margin-top:5px;margin-bottom:0px;">Identify appropriate strategies for evaluating patients with relapsed/refractory differentiated thyroid cancer</li>
                                        </ul>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>


                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Provider</h2>

                                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This activity is provided by prIME Oncology.</p>

                                        <div align="center">
                                            <img src="http://www.primeoncology.org/live_education/heme/~/media/Images/Sponsor/prime.ashx" alt="ACCME" width="112" height="66" />
                                        </div>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>


                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Continuing Education</h2>

                                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">prIME Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME&reg;) to provide continuing medical education for physicians.</p>

                                        <div align="center">
                                            <img src="http://www.primeoncology.org/online_education/solid_tumor/2013/~/media/Images/Sponsor/small_logos/accme.ashx" alt="ACCME" width="112" height="66" />
                                        </div>

                                        <p colspan="3" style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">prIME Oncology designates this enduring activity for a maximum of <em>0.5 AMA PRA Category 1 Credits<sup>TM</sup></em>. Physicians should claim only the credit commensurate with the extent of their participation in the activity.</p>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>


                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Support</h2>

                                        <p colspan="3" style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This educational activity is supported by grants from Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals.</p>

                                        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                                            ___________________________________________________________</p>


                                        <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Other prIME Activities</h2>

                                        <table cellpadding="0" cellspacing="5" border="0" align="center">
                                            <tr valign="top">
                                                <td align="center">
                                                    <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/heme/2014/cml-jabbour.aspx">
                                                        <img src="http://www.primeoncology.org/online_education/~/media/Images/Activity/Interactive%20Clinical%20scenario/listing%20image.ashx" alt="online activity" style="border-style:none" />
                                                        <br/>Interactive Clinical Scenario: Early Milestones and Monitoring in Patients with CML
                                                    </a>
                                                </td>

                                                <td align="center">
                                                    <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/heme/2014/emory-ddho-pds.aspx">
                                                        <img src="http://www.primeoncology.org/~/media/Images/Activity/2011/SABCS/PDS/prIME_DS_SABCS_Banner_177x125.ashx" alt="online activity" style="border-style:none" />
                                                        <br/>Debates and Didactics in Hematology and Oncology
                                                    </a>
                                                </td>

                                                <td align="center">
                                                    <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/heme/2014/chicagocllinhl2014_webcast.aspx">
                                                        <img src="http://www.primeoncology.org/~/media/Images/Activity/2014/asco/cll_inhl/PI4LSS045-CLL-iHNL-Have-Heard-Latest-Banner_177x125.ashx" alt="online activity" style="border-style:none" />
                                                        <br/>Have You Heard the Latest? Updates and Advances in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma
                                                    </a>
                                                </td>
                                            </tr>
                                        </table>
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                    <!--       footer -->
                    <tr style="background-color: #666666;">
                        <td>
                            <table width="100%" style="border-right:solid #0F509B 7px; border-left:solid #0F509B 7px;border-bottom:solid #0F509B 7px;" border="0">
                                <tr>
                                    <td align="center">
                                        <table cellpadding="0" cellspacing="0" style="color: #fff; padding: 30px 10px 10px 30px; font-family:Arial, Helvetica, sans-serif;font-size: 12px; font-weight: normal;" border="0">
                                            <tr valign="top">
                                                <td style="padding-right: 6px;" align="right">
                                                    <img src="http://www.primeoncology.org/~/media/Images/Image%20Links/mobile.ashx" alt="icon" width="32" height="32" border="0" />
                                                </td>
                                                <td style="padding-bottom: 15px;">
                                                    <strong>Get the prIME Oncology app</strong>
                                                    <br />
                                                    <a style="color: #fd8332; text-decoration: none; font-weight: bold;" href="https://itunes.apple.com/us/app/prime-oncology/id681001525?ls=1&mt=8">iPhone</a>
                                                    <span> | </span>
                                                    <a style="color: #fd8332; text-decoration: none; font-weight: bold;" href="https://play.google.com/store/apps/details?id=com.primeoncology.mobile&hl=en">Android</a>
                                                </td>
                                            </tr>
                                        </table>
                                    </td>
                                    <td align="center">
                                        <a style="padding-left: 10px;" href="https://plus.google.com/109069474896753641435">
                                            <img alt='google' src="http://www.primeoncology.org/~/media/Images/Image%20Links/google.ashx" />
                                        </a>
                                        <a style="padding-left: 10px;" href="https://twitter.com/prIME_Oncology">
                                            <img alt='twitter' src="http://www.primeoncology.org/~/media/Images/Image%20Links/twitter.ashx" />
                                        </a>
                                        <a style="padding-left: 10px;" href="http://www.youtube.com/user/prIMEOncologyUpdate">
                                            <img alt='youtube' src="http://www.primeoncology.org/~/media/Images/Image%20Links/youtube.ashx" />
                                        </a>
                                        <a style="padding-left: 10px;" href="http://www.facebook.com/pages/Prime-Oncology/364934120249753">
                                            <img alt='facebook' src="http://www.primeoncology.org/~/media/Images/Image%20Links/facebook.ashx" />
                                        </a>
                                        <a style="padding-left: 10px;" href="http://www.linkedin.com/company/prime-oncology/">
                                            <img alt='linkedin' src="http://www.primeoncology.org/~/media/Images/Image%20Links/linkedin.ashx" />
                                        </a>
                                    </td>
                                </tr>

                                <tr>
                                    <td colspan="2" align="center">
                                        <table width="100%">
                                            <tr>
                                                <td width="36%" align="right">
                                                    <img hspace="15" src="http://primehc.org/email/images/logos/prime.png" alt="prIME Oncology" width="45" height="27" style="vertical-align: top;" border="0">
                                                </td>
                                                <td width="64%">
                                                    <p style="font-size: 10px;color: #bbb;font-family: Arial; text-align:left;">
                                                         Schenkkade 50 | Suite 16 | 2595 AR The Hague | the Netherlands
                                                        <br>2 Concourse Parkway | Suite 270 | Atlanta, Georgia | 30328 USA
                                                    </p>
                                                </td>
                                            </tr>
                                        </table>
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
            </td>
        </tr>
    </table>
</body>

</html>